
Alzamend Neuro, Inc. (ALZN) Dividend History
Alzamend Neuro, Inc. (ALZN) is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and psychiatric disorders. The company's pipeline primarily includes therapies targeting conditions such as Alzheimer's disease, with an emphasis on novel approaches to address unmet medical needs in mental health and neurological health.
Dividend History
Alzamend Neuro, Inc. currently does not pay dividends
Company News
-
The Motley Fool
-
Zacks Investment Research
Page data last updated 07/23/2025 16:19:58 UTC